​

Carlsmed Stock (NASDAQ:CARL)

RevenueOwnershipFinancialsChartTranscripts
Carlsmed by TradingView

Previous Close

$16.50

52W Range

$8.50 - $17.23

50D Avg

$12.18

200D Avg

$11.94

Market Cap

$436.32M

Avg Vol (3M)

$152.62K

Beta

1.77

Div Yield

-

CARL Company Profile

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

127

IPO Date

Jul 23, 2025

Website

CARL Performance

CARL Financial Summary

Dec 25Dec 24Dec 23
Revenue$50.51M$27.16M$13.78M
Operating Income$-30.57M$-24.12M$-18.59M
Net Income$-30.22M$-24.26M$-18.90M
EBITDA$-28.51M$-22.79M$-18.12M
Basic EPS$-2.12$-1.50$-4.25
Diluted EPS$-2.12$-1.50$-4.25

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q1 26May 05, 26 | 12:00 AM
Q4 25Feb 25, 26 | 4:30 PM